Gynaecological Surgery

Gynaecological surgery not only requires control of bleeding and oozing across broad surfaces, but also requires physicians to maintain fertility in many of their patients. Baxter's haemostats and sealants help patients heal quicker and with fewer complications, while Baxter's adhesion reduction agents help reduce post - operative adhesions.

Key Procedures

Each gynaecological procedure presents unique challenges that can cause complications for the healing process. Here are a few examples.

Floseal banner

Hysterectomy

FLOSEAL, Baxter’s flowable haemostat, provides quicker haemostasis (2 minutes median time to haemostasis) that stops many different types of bleeds.1 It can be applied across several procedures on appropriate grades of bleedings (e.g. in hysterectomy).

Learn more about FLOSEAL >

Image of TISSEEL product in applicator next to TISSEEL logo

Myomectomy

Bleeding during and/or after a myomectomy can lead to different kind of complications such as a return to the operating room. TISSEEL, Baxter’s fibrin sealant, mimics a physiological clot for resorption in 10-14 days5, has a broad indication for haemostasis and with a wide range of drip and spray applicators may be applied across several procedures on appropriate grades of bleedings  (e.g. in myomectomy).

Learn more about TISSEEL >

Gynaecologic Laparoscopy

COSEAL Surgical Sealant is a fully synthetic resorbable hydrogel, designed to provide a rapid intraoperative seal and to maintain adhesion protection during the critical postoperative period.3

ADEPT® Adhesion Reduction Solution is a non-viscous, colorless liquid that contains 4% icodextrin. The solution provides broad coverage, temporary tissue separation, and serves as an irrigant throughout surgery.4 

Learn more about COSEAL >

Learn more about ADEPT® >

Portfolio of Products

 

Prescribing Information:

UK flag UK TISSEEL      

 

Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse Event and Product Complaint Handling

Adverse Events should also be reported to Baxter Healthcare Ltd, by email ([email protected]) or by phone (+44) 01635 260360

Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd by email ([email protected]) or by phone (+44 1604 704603).